Int Arch Otorhinolaryngol 2016; 20(03): 212-217
DOI: 10.1055/s-0036-1572430
Original Research
Thieme Publicações Ltda Rio de Janeiro, Brazil

Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2

Carlos Miguel Chiesa Estomba
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
,
Frank Alberto Betances Reinoso
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
,
Alejandra Osorio Velasquez
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
,
Jose Luis Rodriguez Fernandez
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
,
Jose Luis Fariña Conde
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
,
Carmelo Santidrian Hidalgo
1   Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Vigo, Vigo, Pontevedra, Spain
› Author Affiliations
Further Information

Publication History

09 June 2015

06 November 2015

Publication Date:
15 February 2016 (online)

Abstract

Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing itself as an effective option in treatment of glottic, supraglottic, and hypopharynx tumors. Its advantages include limited resections, a reduction in number of tracheostomies, and the use of nasogastric tubes. Moreover, its oncological benefits are similar to those from open surgery in patients with early or advanced stages, when correctly selected.

Objective The objective of this study is to review oncologic outcomes obtained with the treatment of a series of glottic tumors, treated by TLM.

Methods Retrospective analysis of patients previously untreated, diagnosed with squamous cell carcinoma of the glottis (T1a, T1b, T2) in a tertiary university hospital. Endpoints for analysis were local control, overall and disease-specific survival, and larynx preservation rate.

Results The study group included 58 patients that met the inclusion criteria: 57 (98.3%) men and 1 (1.7%) woman. Mean age was 65.5 ± 10.7 years (Min: 46/Max: 88). The tumor stages of the patients included were 30 T1a, 11 (19%) T1b, and 17 (29.3%) T2. Three-year overall survival rate was 89.7% (Fig. 1), and three-year disease-specific survival rate was 96.5%, three-year local control rate was 98.3%, and three-year organ preservation rate was 98.3%.

Conclusion TLM is a safe and effective option in the treatment of glottis carcinomas, associated with less morbidity and a high percentage of local control, overall survival, specific survival, and organ preservation.

 
  • References

  • 1 Strong MS, Jako GJ. Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 1972; 81 (6) 791-798
  • 2 Strong MS. Laser excision of carcinoma of the larynx. Laryngoscope 1975; 85 (8) 1286-1289
  • 3 Vilaseca-González I, Bernal-Sprekelsen M, Blanch-Alejandro JL, Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck 2003; 25 (5) 382-388
  • 4 Stoeckli SJ, Schnieper I, Huguenin P, Schmid S. Early glottic carcinoma: treatment according patient's preference?. Head Neck 2003; 25 (12) 1051-1056
  • 5 Steiner W, Ambrosch P. Advantages of transoral laser microsurgery over standard therapy. In: Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart: Georg Thieme Verlag; 2000: 44-45
  • 6 Bradley PJ, Mackenzie K, Wight R, Pracy P, Paleri V ; ENT-UK Head & Neck Group. Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottic cancer. Clin Otolaryngol 2009; 34 (4) 367-373
  • 7 McCoul ED, Har-El G. Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma. Arch Otolaryngol Head Neck Surg 2009; 135 (5) 479-486
  • 8 Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer 2004; 100 (9) 1786-1792
  • 9 Remacle M, Van Haverbeke C, Eckel H , et al. Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol 2007; 264 (5) 499-504
  • 10 Dey P, Arnold D, Wight R, MacKenzie K, Kelly C, Wilson J. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2002; (2) CD002027
  • 11 Lee HS, Chun BG, Kim SW , et al. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope 2013; 123 (11) 2670-2674
  • 12 Lester SE, Rigby MH, Taylor SM. Transoral laser microsurgery outcomes with early glottic cancer: the Dalhousie University experience. J Laryngol Otol 2011; 125 (5) 509-512
  • 13 Lucioni M, Marioni G, Bertolin A, Giacomelli L, Rizzotto G. Glottic laser surgery: outcomes according to 2007 ELS classification. Eur Arch Otorhinolaryngol 2011; 268 (12) 1771-1778
  • 14 Mortuaire G, Francois J, Wiel E, Chevalier D. Local recurrence after CO2 laser cordectomy for early glottic carcinoma. Laryngoscope 2006; 116 (1) 101-105
  • 15 Sigston E, de Mones E, Babin E , et al. Early-stage glottic cancer: oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg 2006; 132 (2) 147-152
  • 16 Hinni ML, Ferlito A, Brandwein-Gensler MS , et al. Surgical margins in head and neck cancer: a contemporary review. Head Neck 2013; 35 (9) 1362-1370
  • 17 Ansarin M, Cattaneo A, Santoro L , et al. Laser surgery of early glottic cancer in elderly. Acta Otorhinolaryngol Ital 2010; 30 (4) 169
  • 18 Crespo AN, Chone CT, Gripp FM, Spina AL, Altemani A. Role of margin status in recurrence after CO2 laser endoscopic resection of early glottic cancer. Acta Otolaryngol 2006; 126 (3) 306-310
  • 19 Hartl DM, de Monès E, Hans S, Janot F, Brasnu D. Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 2007; 116 (11) 832-836
  • 20 Blanch JL, Vilaseca I, Bernal-Sprekelsen M , et al. Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol 2007; 264 (9) 1045-1051
  • 21 Olthoff A, Ewen A, Wolff HA , et al. Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 2009; 185 (5) 303-309
  • 22 Vilaseca I, Bernal-Sprekelsen M. Transoral laser microsurgery for locally advanced laryngeal cancer. Acta Otorrinolaringol Esp 2013; 64 (2) 140-149
  • 23 Vilaseca I, Ballesteros F, Martínez-Vidal BM, Lehrer E, Bernal-Sprekelsen M, Blanch JL. Quality of life after transoral laser microresection of laryngeal cancer: a longitudinal study. J Surg Oncol 2013; 108 (1) 52-56
  • 24 van Gogh CD, Verdonck-de Leeuw IM, Wedler-Peeters J, Langendijk JA, Mahieu HF. Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2012; 269 (6) 1647-1652
  • 25 Remmelts AJ, Hoebers FJ, Klop WM, Balm AJ, Hamming-Vrieze O, van den Brekel MW. Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice. Eur Arch Otorhinolaryngol 2013; 270 (7) 2079-2087
  • 26 Greulich MT, Parker NP, Lee P, Merati AL, Misono S. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis. Otolaryngol Head Neck Surg 2015; 152 (5) 811-819